694 related articles for article (PubMed ID: 25469009)
1. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C infection before and after liver transplantation.
Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
[TBL] [Abstract][Full Text] [Related]
3. Current management and perspectives for HCV recurrence after liver transplantation.
Coilly A; Roche B; Samuel D
Liver Int; 2013 Feb; 33 Suppl 1():56-62. PubMed ID: 23286847
[TBL] [Abstract][Full Text] [Related]
4. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.
Coilly A; Roche B; Dumortier J; Leroy V; Botta-Fridlund D; Radenne S; Pageaux GP; Si-Ahmed SN; Guillaud O; Antonini TM; Haïm-Boukobza S; Roque-Afonso AM; Samuel D; Duclos-Vallée JC
J Hepatol; 2014 Jan; 60(1):78-86. PubMed ID: 23994384
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for viral hepatitis in 2015.
Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
Price JC; Terrault NA
Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
10. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.
Cholongitas E; Pipili C; Papatheodoridis G
World J Gastroenterol; 2015 Aug; 21(32):9526-33. PubMed ID: 26327760
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C virus infection after liver transplantation.
Agarwal K; Barnabas A
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S349-54. PubMed ID: 24091115
[TBL] [Abstract][Full Text] [Related]
12. News and challenges in the treatment of hepatitis C in liver transplantation.
Coilly A; Roche B; Duclos-Vallée JC; Samuel D
Liver Int; 2016 Jan; 36 Suppl 1():34-42. PubMed ID: 26725895
[TBL] [Abstract][Full Text] [Related]
13. Management of HCV transplant patients with triple therapy.
Coilly A; Roche B; Duclos-Vallée JC; Samuel D
Liver Int; 2014 Feb; 34 Suppl 1():46-52. PubMed ID: 24373078
[TBL] [Abstract][Full Text] [Related]
14. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
15. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
[TBL] [Abstract][Full Text] [Related]
16. Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance.
Roche B; Coilly A; Roque-Afonso AM; Samuel D
Viruses; 2015 Sep; 7(9):5155-68. PubMed ID: 26404355
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C: New challenges in liver transplantation.
Filipec Kanizaj T; Kunac N
World J Gastroenterol; 2015 May; 21(19):5768-77. PubMed ID: 26019441
[TBL] [Abstract][Full Text] [Related]
18. Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
Weiler N; Zeuzem S; Welker MW
World J Gastroenterol; 2016 Nov; 22(41):9044-9056. PubMed ID: 27895394
[TBL] [Abstract][Full Text] [Related]
19. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
Ueda Y; Uemoto S
Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
[TBL] [Abstract][Full Text] [Related]
20. Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir.
Marquez-Azalgara V; Hussaini T; Erb SR; Yoshida EM
Ann Hepatol; 2014; 13(5):565-7. PubMed ID: 25152991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]